Restricted accessResearch articleFirst published online 2015-01
The Angiotensin-Converting Enzyme 2/Angiotensin (1–7)/Mas Axis Protects Against Lung Fibroblast Migration and Lung Fibrosis by Inhibiting the NOX4-Derived ROS-Mediated RhoA/Rho Kinase Pathway
Reactive oxygen species (ROS) generated by NADPH oxidase-4 (NOX4) have been shown to initiate lung fibrosis. The migration of lung fibroblasts to the injured area is a crucial early step in lung fibrosis. The angiotensin-converting enzyme 2 (ACE2)/angiotensin (1–7) [Ang(1–7)]/Mas axis, which counteracts the ACE/angiotensin II (AngII)/angiotensin II type 1 receptor (AT1R) axis, has been shown to attenuate pulmonary fibrosis. Nevertheless, the exact molecular mechanism remains unclear. Aims: To investigate the different effects of the two axes of the renin-angiotensin system (RAS) on lung fibroblast migration and extracellular matrix accumulation by regulating the NOX4-derived ROS-mediated RhoA/Rho kinase (Rock) pathway. Results:In vitro, AngII significantly increased the NOX4 level and ROS production in lung fibroblasts, which stimulated cell migration and α-collagen I synthesis through the RhoA/Rock pathway. These effects were attenuated by N-acetylcysteine (NAC), diphenylene iodonium, and NOX4 RNA interference. Moreover, Ang(1–7) and lentivirus-mediated ACE2 (lentiACE2) suppressed AngII-induced migration and α-collagen I synthesis by inhibiting the NOX4-derived ROS-mediated RhoA/Rock pathway. However, Ang(1–7) alone exerted analogous effects on AngII. In vivo, constant infusion with Ang(1–7) or intratracheal instillation with lenti-ACE2 shifted the RAS balance toward the ACE2/Ang(1–7)/Mas axis, alleviated bleomycin-induced lung fibrosis, and inhibited the RhoA/Rock pathway by reducing NOX4-derived ROS. Innovation: This study suggests that the ACE2/Ang(1–7)/Mas axis may be targeted by novel pharmacological antioxidant strategies to treat lung fibrosis induced by AngII-mediated ROS. Conclusion: The ACE2/Ang(1–7)/Mas axis protects against lung fibroblast migration and lung fibrosis by inhibiting the NOX4-derived ROS-mediated RhoA/Rock pathway. Antioxid. Redox Signal. 22, 241–258.
Get full access to this article
View all access options for this article.
References
1.
AmaraN, GovenD, ProstF, MulowayR, CrestaniB, and BoczkowskiJ. NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFbeta1-induced fibroblast differentiation into myofibroblast. Thorax, 65: 733–738, 2010.
2.
AmbastaRK, KumarP, GriendlingKK, et al. Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J Biol Chem, 279: 45935–45941, 2004.
AshcroftT, SimpsonJM, and TimbrellV. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol, 41: 467–470, 1988.
5.
BatallerR, SchwabeRF, Choi YH, YangL, PaikYH, LindquistJ, QianT, SchoonhovenR, HagedornCH, LemastersJJ, and BrennerDA. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J Clin Invest, 112: 1383–1394, 2003.
6.
BedardK and KrauseKH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev, 87: 245–313, 2007.
7.
BocchinoM, AgneseS, FagoneE, SvegliatiS, GriecoD, VancheriC, GabrielliA, SanduzziA, and AvvedimentoEV. Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis. PLoS One, 5: e14003, 2010.
8.
BrownDI and GriendlingKK. Nox proteins in signal transduction. Free Radic Biol Med, 47: 1239–1253, 2009.
9.
CaiGQ, ZhengA, TangQ, WhiteES, ChouCF, GladsonCL, OlmanMA, and DingQ. Downregulation of FAK-related non-kinase mediates the migratory phenotype of human fibrotic lung fibroblast. Exp Cell Res, 316: 1600–1609, 2010.
10.
CarnesecchiS, DeffertC, DonatiY, BassetO, HinzB, Preynat-SeauveO, GuichardC, ArbiserJL, BanfiB, PacheJC, Barazzone-ArgiroffoC, and KrauseKH. A key role for NOX4 in epithelial cell death during development of lung fibrosis. Antioxid Redox Signal, 15: 607–619, 2011.
11.
ChenJ, XiaoX, ChenS, ZhangC, ChenJ, YiD, ShenoyV, RaizadaMK, ZhaoB, and ChenY. Angiotensin-converting enzyme 2 priming enhances the function of endothelial progenitor cells and their therapeutic efficacy. Hypertension, 61: 681–689, 2013.
12.
CookKL, Metheny-BarlowLJ, TallantEA, and GallagherPE. Angiotensin-(1–7) reduces fibrosis in orthotopic breast tumors. Cancer Res, 70: 8319–8328, 2010.
13.
GianiJF, GironacciMM, MunozMC, TurynD, and DominiciFP. Angiotensin-(1–7) has a dual role on growth-promoting signalling pathways in rat heart in vivo by stimulating STAT3 and STAT5a/b phosphorylation and inhibiting angiotensin II-stimulated ERK1/2 and Rho kinase activity. Exp Physiol, 93: 570–578, 2008.
14.
GoldsteinRH and FineA. Fibrotic reactions in the lung: the activation of the lung fibroblast. Exp Lung Res, 11: 245–261, 1986.
15.
HagiwaraSI, IshiiY, and KitamuraS. Aerosolized administration of N-acetylcysteine attenuates lung fibrosis induced by bleomycin in mice. Am J Respir Crit Care Med, 162: 225–231, 2000.
16.
HeckerL, ChengJ, and ThannickalVJ. Targeting NOX enzymes in pulmonary fibrosis. Cell Mol Life Sci, 69: 2365–2371, 2012.
17.
HeckerL, VittalR, JonesT, JagirdarR, LuckhardtTR, HorowitzJC, PennathurS, MartinezFJ, and ThannickalVJ. NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat Med, 15: 1077–1081, 2009.
18.
HsuHH, HoffmannS, EndlichN, VelicA, SchwabA, WeideT, SchlatterE, and PavenstadtH. Mechanisms of angiotensin II signaling on cytoskeleton of podocytes. J Mol Med (Berl), 86: 1379–1394, 2008.
19.
JiangT, GaoL, ShiJ, LuJ, WangY, and ZhangY. Angiotensin-(1–7) modulates renin-angiotensin system associated with reducing oxidative stress and attenuating neuronal apoptosis in the brain of hypertensive rats. Pharmacol Res, 67: 84–93, 2013.
20.
KlimentCR and OuryTD. Oxidative stress, extracellular matrix targets, and idiopathic pulmonary fibrosis. Free Radic Biol Med, 49: 707–717, 2010.
KonigshoffM, WilhelmA, JahnA, SeddingD, AmarieOV, EulB, SeegerW, FinkL, GuntherA, EickelbergO, and RoseF. The angiotensin II receptor 2 is expressed and mediates angiotensin II signaling in lung fibrosis. Am J Respir Cell Mol Biol, 37: 640–650, 2007.
23.
KostenisE, MilliganG, ChristopoulosA, Sanchez-FerrerCF, Heringer-WaltherS, SextonPM, GembardtF, KellettE, MartiniL, VanderheydenP, SchultheissHP, and WaltherT. G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor. Circulation, 111: 1806–1813, 2005.
24.
LambethJD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol, 4: 181–189, 2004.
25.
LangYD, HungCL, WuTY, WangLF, and ChenCM. The renin-angiotensin system mediates hyperoxia-induced collagen production in human lung fibroblast. Free Radic Biol Med, 49: 88–95, 2010.
26.
LyleAN, DeshpandeNN, TaniyamaY, Seidel-RogolB, PounkovaL, DuP, PapaharalambusC, LassegueB, and GriendlingKK. Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells. Circ Res, 105: 249–259, 2009.
27.
ManouryB, NenanS, LeclercO, GuenonI, BoichotE, PlanquoisJM, BertrandCP, and LagenteV. The absence of reactive oxygen species production protects mice against bleomycin-induced pulmonary fibrosis. Respir Res, 6: 11, 2005.
28.
MarshallRP, GohlkeP, ChambersRC, HowellDC, BottomsSE, UngerT, McAnultyRJ, and LaurentGJ. Angiotensin II and the fibroproliferative response to acute lung injury. Am J Physiol Lung Cell Mol Physiol, 286: L156–L164, 2004.
29.
MartynKD, FrederickLM, von LoehneysenK, DinauerMC, and KnausUG. Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell Signal, 18: 69–82, 2006.
30.
MengY, YuCH, LiW, LiT, LuoW, HuangS, WuPS, CaiSX, and LiX. Angiotensin-converting enzyme 2/angiotensin-(1–7)/Mas axis protects against lung fibrosis by inhibiting the MAPK/NF-κB pathway. Am J Respir Cell Mol Biol, 50: 723–736, 2014.
31.
MontezanoAC, CalleraGE, YogiA, HeY, TostesRC, HeG, SchiffrinEL, and TouyzRM. Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-regulated redox-sensitive RhoA pathways. Arterioscler Thromb Vasc Biol, 28: 1511–1518, 2008.
32.
MoonJY, TanimotoM, GohdaT, HagiwaraS, YamazakiT, OharaI, MurakoshiM, AokiT, IshikawaY, LeeSH, JeongKH, LeeTW, IhmCG, LimSJ, and TominoY. Attenuating effect of angiotensin-(1–7) on angiotensin II-mediated NAD(P)H oxidase activation in type 2 diabetic nephropathy of KK-AyTa mice. Am J Physiol Renal Physiol, 6: F1271–F1282, 2011.
33.
NiJ, DongZ, HanW, KondrikovD, and SuY. The role of RhoA and cytoskeleton in myofibroblast transformation in hyperoxic lung fibrosis. Free Radic Biol Med, 61C: 26–39, 2013.
34.
NiL, FengY, WanH, MaQ, FanL, QianY, LiQ, XiangY, and GaoB. Angiotensin-(1–7) inhibits the migration and invasion of A549 human lung adenocarcinoma cells through inactivation of the PI3K/Akt and MAPK signaling pathways. Oncol Rep, 27: 783–790, 2012.
35.
NlanduKS, DizinE, SossauerG, SzantoI, MartinPY, FerailleE, KrauseKH, and de SeigneuxS. NADPH-oxidase 4 protects against kidney fibrosis during chronic renal injury. J Am Soc Nephrol, 23: 1967–1976, 2012.
36.
OtsukaM, TakahashiH, ShiratoriM, ChibaH, and AbeS. Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist. Thorax, 59: 31–38, 2004.
37.
ParkS, AhnJY, LimMJ, KimMH, YunYS, JeongG, and SongJY. Sustained expression of NADPH oxidase 4 by p38 MAPK-Akt signaling potentiates radiation-induced differentiation of lung fibroblast. J Mol Med (Berl), 88: 807–816, 2010.
SerranderL, CartierL, BedardK, BanfiB, LardyB, PlastreO, SienkiewiczA, ForroL, SchlegelW, and KrauseKH. NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. Biochem J, 406: 105–114, 2007.
40.
Serrano-MollarA, ClosaD, PratsN, BlesaS, Martinez-LosaM, CortijoJ, EstrelaJM, MorcilloEJ, and BulbenaO. In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats. Br J Pharmacol, 138: 1037–1048, 2003.
41.
ShenoyV, FerreiraAJ, QiY, Fraga-SilvaRA, Díez-FreireC, DooiesA, JunJY, SriramulaS, MariappanN, PourangD, VenugopalCS, FrancisJ, ReudelhuberT, SantosRA, PatelJM, RaizadaMK, and KatovichMJ. The angiotensin-converting enzyme 2/angiogenesis-(1–7)/Mas axis confers cardiopulmonary protectionagainst lung fibrosis and pulmonary hypertension. Am J Respir Crit Care Med, 182: 1065–1072, 2010.
42.
ShinoharaM, ShangWH, KuboderaM, HaradaS, MitsushitaJ, KatoM, MiyazakiH, SumimotoH, and KamataT. Nox1 redox signaling mediates oncogenic Ras-induced disruption of stress fibers and focal adhesions by down-regulating Rho. J Biol Chem, 282: 17640–17648, 2007.
43.
SuganumaH, SatoA, TamuraR, and ChidaK. Enhaced migration of fibroblasts derived from lungs with fibrotic lesions. Thorax, 50: 984–989, 1995.
44.
TakahashiF, TakahashiK, OkazakiT, MaedaK, IenagaH, MaedaM, KonS, UedeT, and FukuchiY. Role of osteopontin in the pathogenesis of bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol, 24: 264–271, 2001.
45.
ThomasJ, GrossMD, GaryW, and HunningchakeMD. Idiopathic pulmonary fibrosis. N Engl J Med, 345: 517–525, 2001.
46.
TufvessonE and Westergren-ThorssonG. Biglycan and decorin induce morphological and cytoskeletal changes involving signalling by the small GTPases RhoA and Rac1 resulting in lung fibroblast migration. J Cell Sci, 116: 4857–4864, 2003.
47.
Ushio-FukaiM, HilenskiL, SantanamN, BeckerPL, MaY, GriendlingKK, and AlexanderRW. Cholesterol depletion inhibits epidermal growth factor receptor transactivation by angiotensin II in vascular smooth muscle cells: role of cholesterol-rich microdomains and focal adhesions in angiotensin II signaling. J Biol Chem, 276: 48269–48275, 2001.
48.
WhiteES, ThannickalVJ, CarskadonSL, DickieEG, LivantDL, MarkwartS, ToewsGB, and ArenbergDA. Integrin α4β1 regulates migration across basement membranes by lung fibroblasts: a role for phosphatase and tensin homologue deleted on chromosome 10. Am J Respir Crit Care Med, 168: 436–442, 2003.
49.
WinglerK, WunschS, KreutzR, RothermundL, PaulM, and SchmidtHH. Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo. Free Radic Biol Med, 31: 1456–1464, 2001.
50.
WuRF, MaZ, MyersDP, and TeradaLS. HIV-1 Tat activates dual Nox pathways leading to independent activation of ERK and JNK MAP kinases. J Biol Chem, 282: 37412–37419, 2007.
51.
XiaH, SudaS, BindomS, FengY, GurleySB, SethD, NavarLG, and LazartiguesE. ACE2-mediated reduction of oxidative stress in the central nervous system is associated with improvement of autonomic function. PLoS One, 6: e22682, 2011.
52.
YamagishiS, NakamuraK, UedaS, KatoS, and ImaizumiT. Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF. Cell Tissue Res, 320: 437–445, 2005.
53.
YangJ, TanY, ZhaoF, MaZ, WangY, ZhengS, EpsteinPN, YuJ, YinX, ZhengY, LiX, MiaoL, and CaiL. Angiotensin II plays a critical role in diabetic pulmonary fibrosis most likely via activation of NADPH oxidase-mediated nitrosative damage. Am J Physiol Endocrinol Metab, 301: E132–E144, 2011.
54.
ZhangC, ZhaoYX, ZhangYH, ZhuL, DengBP, ZhouZL, LiSY, LuXT, SongLL, LeiXM, TangWB, WangN, PanCM, SongHD, LiuCX, DongB, ZhangY, and CaoY. Angiotensin-converting enzyme 2 attenuates atherosclerotic lesions by targeting vascular cells. Proc Natl Acad Sci U S A, 107: 15886–15891, 2010.
55.
ZhangF, HuY, XuQ, and YeS. Different effects of angiotensin II and angiotensin-(1–7) on vascular smooth muscle cell proliferation and migration. PLoS One, 5: e12323, 2010.
56.
ZhangR, WuY, ZhaoM, LiuC, ZhouL, ShenS, LiaoS, YangK, LiQ, and WanH. Role of HIF-1alpha in the regulation ACE and ACE2 expression in hypoxic human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol, 297: L631–L640, 2009.
57.
ZhaoW, ChenSS, ChenY, AhokasRA, and SunY. Kidney fibrosis in hypertensive rats: role of oxidative stress. Am J Nephrol, 28: 548–554, 2008.
58.
ZhaoW, ZhaoT, ChenY, AhokasRA, and SunY. Oxidative stress mediates cardiac fibrosis by enhancing transforming growth factor-beta1 in hypertensive rats. Mol Cell Biochem, 317: 43–50, 2008.
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
